- Home
- CLST vs IMMX Comparison
CLST vs IMMX Comparison
Compare CLST & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- IMMX
- Stock Information
- Founded
- CLST 1922
- IMMX 2014
- Country
- CLST United States
- IMMX United States
- Employees
- CLST N/A
- IMMX N/A
- Industry
- CLST
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- CLST
- IMMX Health Care
- Exchange
- CLST Nasdaq
- IMMX Nasdaq
- Market Cap
- CLST 52.2M
- IMMX 51.1M
- IPO Year
- CLST N/A
- IMMX 2021
- Fundamental
- Price
- CLST $11.35
- IMMX $1.45
- Analyst Decision
- CLST
- IMMX Strong Buy
- Analyst Count
- CLST 0
- IMMX 1
- Target Price
- CLST N/A
- IMMX $7.00
- AVG Volume (30 Days)
- CLST 10.5K
- IMMX 148.3K
- Earning Date
- CLST 10-24-2024
- IMMX 11-11-2024
- Dividend Yield
- CLST N/A
- IMMX N/A
- EPS Growth
- CLST N/A
- IMMX N/A
- EPS
- CLST N/A
- IMMX N/A
- Revenue
- CLST $4,388,000.00
- IMMX N/A
- Revenue This Year
- CLST N/A
- IMMX N/A
- Revenue Next Year
- CLST N/A
- IMMX $200.00
- P/E Ratio
- CLST N/A
- IMMX N/A
- Revenue Growth
- CLST N/A
- IMMX N/A
- 52 Week Low
- CLST $10.60
- IMMX $1.26
- 52 Week High
- CLST $12.10
- IMMX $7.75
- Technical
- Relative Strength Index (RSI)
- CLST 49.49
- IMMX 39.98
- Support Level
- CLST $11.32
- IMMX $1.26
- Resistance Level
- CLST $11.44
- IMMX $1.80
- Average True Range (ATR)
- CLST 0.17
- IMMX 0.16
- MACD
- CLST 0.02
- IMMX 0.00
- Stochastic Oscillator
- CLST 54.72
- IMMX 35.19
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.